ArticleNeurochemical research2026
β-Lapachone-Induced Oxidative Stress Causes PARP-Dependent NAD
Article in Neurochemical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oxidative stress has been connected with many brain pathologies. As brain astrocytes have a strong antioxidative potential, we have investigated the consequences of β-lapachone-induced oxidative stress on the cell metabolism of cultured astrocytes by determining the cellular levels of important components of the cellular redox and energy metabolism. β-Lapachone exposure induced a rapid oxidation of cellular NADH and NADPH followed by a time- and concentration-dependent loss in the total cellular NADx content and an increase in the total cellular NADPx content, while the cell viability was not compromised. In addition, the treated cells were partially depleted of ATP and lost their ability to upregulate glycolytic lactate production after exposure to the respiratory chain inhibitor antimycin A. All these consequences were prevented in the presence of ES936 which inhibits the NQO1-mediated reduction of β-lapachone. Inhibition of poly(ADP-ribose) polymerases (PARPs) by PJ34 or AZD-2461 did not affect the strong cellular accumulation of glutathione disulfide, but significantly lowered the oxidative stress-induced loss in the cellular NADx and ATP contents, maintained the ability of the cells to upregulate glycolytic lactate production during incubation with antimycin A, and doubled the increase in the cellular NADPx content. After removal of the β-lapachone-induced oxidative stress, astrocytes were able to restore their initial cellular content of NADx in the presence of the NAD
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.